Fernández-Plaza, S.
González de Pablo, J.
Gálvez, E. https://orcid.org/0000-0002-2330-8257
Zubicaray, J. https://orcid.org/0000-0003-4115-9598
Guillén, M.
Sevilla, J. https://orcid.org/0000-0002-6852-1860
Sebastián, E. https://orcid.org/0000-0002-5444-8076
Article History
Received: 9 October 2020
Revised: 4 February 2021
Accepted: 7 February 2021
First Online: 16 February 2021
Declarations
:
: Ethical approval was evaluated by the local Ethics Committee. This study was approved by the research ethics committee of the Hospital Infantil Universitario Niño Jesús (Registration number: R-0042/16). Given the retrospective nature of the study, and that all the procedures performed were part of routine care, it was not considered necessary to request new informed consents, providing all information is anonymized.
: Julian Sevilla: consultant/advisor/honorarium (Amgen, Novartis, Miltenyi, Sobi, Rocket Pharma). Elena Sebastian: honorarium (Novartis), Josune Zubicaray: honorarium (Novartis). Eva Gálvez: honorarium (Novartis). The other authors declare no competing interests.